tranexamic acid
Generic: tranexamic acid
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
tranexamic acid
Generic Name
tranexamic acid
Labeler
aurobindo pharma limited
Dosage Form
TABLET
Routes
Active Ingredients
tranexamic acid 650 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59651-839
Product ID
59651-839_773eb919-7d48-4ba2-af58-aa169f0ea75f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205133
Listing Expiration
2026-12-31
Marketing Start
2023-12-04
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59651839
Hyphenated Format
59651-839
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tranexamic acid (source: ndc)
Generic Name
tranexamic acid (source: ndc)
Application Number
ANDA205133 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 650 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (59651-839-30)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "773eb919-7d48-4ba2-af58-aa169f0ea75f", "openfda": {"nui": ["N0000175634", "N0000175632"], "unii": ["6T84R30KC1"], "rxcui": ["883826"], "spl_set_id": ["773eb919-7d48-4ba2-af58-aa169f0ea75f"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (59651-839-30)", "package_ndc": "59651-839-30", "marketing_start_date": "20231204"}], "brand_name": "TRANEXAMIC ACID", "product_id": "59651-839_773eb919-7d48-4ba2-af58-aa169f0ea75f", "dosage_form": "TABLET", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "59651-839", "generic_name": "TRANEXAMIC ACID", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TRANEXAMIC ACID", "active_ingredients": [{"name": "TRANEXAMIC ACID", "strength": "650 mg/1"}], "application_number": "ANDA205133", "marketing_category": "ANDA", "marketing_start_date": "20231204", "listing_expiration_date": "20261231"}